摘要
目的：对稳心颗粒联合美托洛尔治疗冠心病心律失常的有效性进行探讨。方法随机选取我院2012年3月～2014年4月收治的60例冠心病心律失常患者，将其分成对照组和观察组，采取不同的方法进行治疗，对比两组患者的治疗效果。结果经治疗后，两组患者在不良反应方面没有明显的差异（P＞0.05），其中，对照组总有效人数22例，观察组总有效人数29例，两组差异有统计学意义（P＜0.05）。结论在冠心病心律失常患者的治疗过程中，稳心颗粒联合美托洛尔明显提高患者的治疗效果，具有较好的安全性。
Objective To discuss the effect of Wenxin Graluna and metoprolol in the treatment of coronary heart arrhythmia. Methods Chose 60 cases of coronary heart arrhythmia in our hospital and divided into control group and observation group, and each group used different treatment, compared the therapeutic effect in the two groups of patients. Results After treatment, there was no signiifcant difference in the no adverse reactions in two groups of patients （P〉0.05）. In the control group, 22 cases were effective, in the observation group, 29 cases were effective, the difference was significant （P〈0.05）. Conclusion In the treatment of coronary heart arrhythmia, the Wenxin graluna and metoprolol can significantly improve patient outcomes and have high better security.
出处
《中国继续医学教育》
2015年第4期260-261,共2页
China Continuing Medical Education
